Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 6
2004 14
2005 11
2006 7
2007 5
2008 10
2009 17
2010 12
2011 4
2012 11
2013 15
2014 10
2015 8
2016 18
2017 16
2018 13
2019 23
2020 17
2021 15
2022 8
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
Editorial note.
Alonso MJ. Alonso MJ. Drug Deliv Transl Res. 2023 Jun;13(6):1543-1545. doi: 10.1007/s13346-023-01340-9. Epub 2023 Apr 18. Drug Deliv Transl Res. 2023. PMID: 37072580 Free PMC article. No abstract available.
Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors.
Anthiya S, Öztürk SC, Yanik H, Tavukcuoglu E, Şahin A, Datta D, Charisse K, Álvarez DM, Loza MI, Calvo A, Sulheim E, Loevenich S, Klinkenberg G, Schmid R, Manoharan M, Esendağlı G, Alonso MJ. Anthiya S, et al. J Control Release. 2023 May;357:67-83. doi: 10.1016/j.jconrel.2023.03.016. Epub 2023 Mar 28. J Control Release. 2023. PMID: 36921725 Free article.
Editorial note.
Alonso MJ. Alonso MJ. Drug Deliv Transl Res. 2021 Apr;11(2):331-333. doi: 10.1007/s13346-021-00947-0. Drug Deliv Transl Res. 2021. PMID: 33655442 No abstract available.
New Editor-in-Chief.
Alonso MJ. Alonso MJ. Drug Deliv Transl Res. 2019 Aug;9(4):737. doi: 10.1007/s13346-019-00647-w. Drug Deliv Transl Res. 2019. PMID: 31098929 No abstract available.
Polymer-based oral peptide nanomedicines.
Herrero EP, Alonso MJ, Csaba N. Herrero EP, et al. Ther Deliv. 2012 May;3(5):657-68. doi: 10.4155/tde.12.40. Ther Deliv. 2012. PMID: 22834409 Review.
Oral Delivery of Biologics for Precision Medicine.
Durán-Lobato M, Niu Z, Alonso MJ. Durán-Lobato M, et al. Adv Mater. 2020 Apr;32(13):e1901935. doi: 10.1002/adma.201901935. Epub 2019 Jun 20. Adv Mater. 2020. PMID: 31222910 Review.
Lipid-based nanocarriers for oral peptide delivery.
Niu Z, Conejos-Sánchez I, Griffin BT, O'Driscoll CM, Alonso MJ. Niu Z, et al. Among authors: alonso mj. Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):337-354. doi: 10.1016/j.addr.2016.04.001. Epub 2016 Apr 11. Adv Drug Deliv Rev. 2016. PMID: 27080735 Review.
My one-year perspective as editor-in-chief of DDTR.
Alonso MJ. Alonso MJ. Drug Deliv Transl Res. 2020 Jun;10(3):565-566. doi: 10.1007/s13346-020-00767-8. Drug Deliv Transl Res. 2020. PMID: 32358722 No abstract available.
232 results